Blog
Better Buy: Western Digital vs. Intel
The past year hasn't been a good one for the semiconductor industry. After a huge surge in demand over 2017 and 2018, the trade war between the U.S. and China led to semiconductor buyers turning
Here's Why WWE Should Drop Its Dividend
WWE (NYSE: WWE) has a dividend -- $0.12 per share in the most recent quarter -- that currently must be paid partly from its cash reserves. The company's net income rose in the second quarter to
HEXO Hit With a Severe Downgrade
This week started out badly for marijuana stock HEXO (NYSE: HEXO).
On Monday -- one working day after announcing the resignation of its CFO -- the company was socked with a drastic downgrade of its
Facebook Settles Inflated Video Metrics Lawsuit for Chump Change
Social networking juggernaut Facebook (NASDAQ: FB) found itself in hot water with advertisers a few years back when it admitted that it had been miscalculating crucial video metrics just as the
How Big a Deal Is Canopy Growth's Recent Sports Beverage Acquisition?
Investors found themselves a little surprised on Friday after the industry's largest cannabis company announced a peculiar acquisition. Canopy Growth (NYSE: CGC) bought a majority stake in BioSteel
3 More Stocks That Have Been Cut in Half in 2019
I recently took a look at several stocks that have shed more than 50% of their value this year. Why stop there? Despite the market in general moving higher in 2019, there are dozens of stocks that
3 Reasons Vertex Pharmaceuticals Is Poised for a Big Year
Investing in biotechnology stocks can sometimes feel more like gambling than serious wealth-building. Company success usually rides on the binary events of clinical trials and regulatory approvals
Should Investors Buy or Sell Sangamo Therapeutics Right Now?
One of the most promising niches in the biotech sector from both a technological and a financial standpoint is the realm of gene editing. Technologies such as CRISPR are enabling a new generation
What Benefits Does Medicare Advantage Offer Over Original Medicare?
Healthcare is always a hot topic, both for investors and for those who need health coverage. With Medicare's open enrollment period quickly approaching, millions of seniors will soon find it's time
Why Honda's Shares Gained Over 10% in September
Shares of Honda Motor (NYSE: HMC) surged last month after the company posted strong August sales despite unfavorable market conditions in the U.S. and China.
Honda's American depositary shares rose
Warren Buffett's Favorite High-Yield Dividend Stocks
Dividend stocks are usually the cornerstone of successful investing portfolios. That's because they bring an abundance of advantages to the table that their non-dividend-paying counterparts simply
Is Walmart Setting Its Sights on the Healthcare Market?
Amazon (NASDAQ: AMZN) dipped another toe into the healthcare business last month, debuting a program for its employees called Amazon Care. The company hasn't spoken of any plans to expand it to the
2 Ways Aurora Cannabis Could Pay the Price for Its Aggressive Growth Strategy
Aurora Cannabis (TSX: ACB) is one of the most popular marijuana companies, particularly among millennials. The pot grower famously ranked as the top stock holding on Robinhood. Aurora isn't just
HEXO's CFO Leaves Unexpectedly: Time to Worry or Time to Buy?
HEXO (NYSE: HEXO) announced the departure of its chief financial officer, Michael Monahan, after the market closed on Friday. Any time a top executive unexpectedly leaves, it raises questions for
Why Momo Stock Fell 16% in September
Shares of Momo (NASDAQ: MOMO) were sliding last month after the Chinese social network and online dating company got swept up in the sell-off in Chinese stocks toward the end of the month. A threat
Should Investors Care About the Not-So Quintessential iRobot Terra?
It seems we are living in the days of the servant robot -- both at home and in the workplace. And riding the smart home trend is iRobot (NASDAQ: IRBT), maker of the autonomous vacuum Roomba. While
These 2 Stocks Were Mashed on Monday
"Can't trust that day," The Mamas and the Papas once sang about Mondays in general.
In addition to the usual aches, pains, and regrets about going back to work following the weekend, owners of some
Why Michaels Stores' Stock Rose 73% Last Month
Shares of Michaels Stores (NASDAQ: MIK) soared 73% higher in September 2019, according to data from S&P Global Market Intelligence. The surge centered on a solid earnings report.
The arts and
Starbucks Stock Looks Like a Deal Right Now
Buying quality is always in style, but in the wake of Starbucks (NASDAQ: SBUX) stock's 15% decline over the last two months, the coffee giant looks even more worthy of serious consideration by
Why Shares of Several Cloud Communications Experts Crashed Last Month
Shares of cloud-based communications specialists had a tough month in September. According to data from S&P Global Market Intelligence, RingCentral 's (NYSE: RNG) shares fell 11% while 8x8 (NYSE:
Here's Why Seattle Genetics Climbed 17.6% in September
Shares of Seattle Genetics (NASDAQ: SGEN) jumped 17.6% in September, according to data provided by S&P Global Market Intelligence, as the biotech rounded out the month with positive data from a pair
Why Intelsat Stock Popped 10.3% in September
Shares of Intelsat (NYSE: I) climbed 10.3% in September, according to data from S&P Global Market Intelligence, as investors anticipate a potentially lucrative deal to pave the way for the satellite
Why SS&C Technologies Stock Jumped 10.6% in September
Shares of SS&C Technologies (NASDAQ: SSNC) climbed 10.6% in September, according to data from S&P Global Market Intelligence, rebounding from a steep drop between late July and early August after
Here’s Why Emergent BioSolutions Stock Climbed 19.4% in September
Shares of Emergent BioSolutions (NYSE: EBS) jumped 19.4% in September, according to data provided by S&P Global Market Intelligence, after the bioterrorism expert was awarded a contract from the
Here's Why Alder Biopharmaceuticals More Than Doubled in September
Shares of Alder Biopharmaceuticals (NASDAQ: ALDR) jumped 111% in September, according to data provided by S&P Global Market Intelligence, after the biotech said it will be acquired by Lundbeck.


